Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
Pharmacological inhibitory profile of TAK-828F, a potent and selective orally available RORγt inverse agonist. [electronic resource] by
- Shibata, Akira
- Uga, Keiko
- Sato, Takayuki
- Sagara, Masaki
- Igaki, Keiko
- Nakamura, Yoshiki
- Ochida, Atsuko
- Kono, Mitsunori
- Shirai, Junya
- Yamamoto, Satoshi
- Yamasaki, Masashi
- Tsuchimori, Noboru
Producer: 20190109
In:
Biochemical pharmacology vol. 150
Availability: No items available.
|
|
6.
|
Gene Signature-Based Approach Identified MEK1/2 as a Potential Target Associated With Relapse After Anti-TNFα Treatment for Crohn's Disease. [electronic resource] by
- Gamo, Kanae
- Okuzono, Yuumi
- Yabuki, Masato
- Ochi, Takashi
- Sugimura, Kyoko
- Sato, Yosuke
- Sagara, Masaki
- Hayashi, Hiroki
- Ishimura, Yoshimasa
- Nishimoto, Yutaka
- Murakawa, Yusuke
- Shiokawa, Zenyu
- Gotoh, Masayuki
- Miyazaki, Takahiro
- Ebisuno, Yukihiko
Producer: 20190628
In:
Inflammatory bowel diseases vol. 24
Availability: No items available.
|